Skip to main content
Explore URMC
menu

IBRT20063 / EF-32 / Nimish Mohile

Basic Study Information

Purpose:
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation therapy and temozolomide alone. In both arms, Optune® and maintenance temozolomide are continued following radiation therapy.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher:  Nimish Mohile

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Return to Search